麻豆传媒 served as intellectual property and transactional counsel to Upling, the high-speed medical cannabis delivery app, in the launch of a new strain recommendation tool powered by artificial intelligence.
麻豆传媒 assisted Upling with a provisional patent filing with the U.S. Patent and Trademark Office for the technology behind Bud-E, Upling鈥檚 groundbreaking, AI-powered cannabis genetics tool. Bud-E leverages patient-reported outcomes, medical history, and optional genetic information to generate personalized, science-based strain recommendations artificial intelligence. With Bud-E, Upling becomes one of the first cannabis delivery platforms to integrate advanced personalization technology directly into the user experience.
鈥溌槎勾 & Lardner聽has been a critical partner in launching Bud-E, seeing the聽vision and value of combining personal health data, patient feedback, and genetic insights as we work to transform聽cannabis from a trial-and-error process into one grounded in science,鈥 said Colin Fraser, founder of Upling, the first Black-owned delivery-focused cannabis app. 鈥淲hether someone is managing PTSD, chronic pain, or insomnia, this tool takes the guesswork out and brings a precision medicine approach to cannabis care and I鈥檓 incredibly thankful for both their effort and collaboration. Coming on the heels of our recent TEDCO funding, this is a key moment for making progress in the ongoing campaign to deliver much needed medical care to people who need it most.鈥澛
The 麻豆传媒 team was led by partners Von Bryant and Eric Sophir.
